NCT00143143

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Pregabalin BID Open-Label Add-On Trial: A Follow-Up Study To Determine Long-Term Safety and Efficacy in Patients With Partial Seizures

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 300 (planned)
• Sponsor: Pfizer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary purpose of the protocol is to evaluate the long-term safety of pregabalin in patients with partial seizures.

Conditions

• Epilepsies, Partial
• Epilepsy, Complex Partial

Interventions

Type	Name	Description
DRUG	Pregabalin

Timeline

• Start date: 2001-09-01
• Completion: 2006-02-01
• First posted: 2005-09-02
• Last updated: 2006-07-24

Locations

47 sites across 8 countries: Austria, Canada, France, Germany, Italy, Lithuania, Spain, United Kingdom